- Login
- Manage Portfolio
- Post a StockTalk
- Write an Instablog
- Get Daily Email Alert
-
Seeking Alpha
-
Thursday, November 26th
Financing Drug Discovery: Recent Deals
-
Friday, November 20th
Competition in Blood - Thinners: Win - Win for Everyone Involved
-
Thursday, November 19th
Cheating Death: Possible Winners and Losers in Life Extension Strategies
-
Monday, November 16th
Cholesterol Drug Trials: A Victory for Abbott Means a Loss for Merck
-
Developments for Parkinson's Disease Ignite Investor Enthusiasm
-
Sunday, November 8th
Cel-Sci, Johns Hopkins Move Forward with LEAPS
-
Thursday, November 5th
Hemispherx Biopharma Could Become a Nice Rebound Story
-
Roche Opens Singapore Manufacturing Facility for Projects Initiated by Genentech
-
Tuesday, November 3rd
Four Biotech Stocks to Play the Sector Pullback
-
Sunday, November 1st
Transcept Pharma Loses Sleep over Insomnia Drug Approval
-
Lilly Hopes New San Diego Facility Will Be 'a Biotechnology Powerhouse'
-
Biotech Tribulations Roundup: Failed Trials, Missed Targets, Business Mishaps
-
This Week in Biotech: More Treats than Tricks
-
Friday, October 30th
Healthcare Profits: Assessing Company Sensitivity to Obamacare
-
Tuesday, October 27th
Antigenics Should Rise on the Promise of Cancer Immunotherapy Treatments
-
Cel-Sci's Targets Stay on Track
-
Thursday, October 22nd
Amgen Q3: Beats Nicely, Raises Guidance
-
Wednesday, October 21st
Earnings Preview: Amgen
-
Wednesday, October 14th
Auxilium Inches Toward FDA Approval for Xiaflex
-
With Promising Cancer Drugs, Genomic Must Still Diversify Its Pipeline
-
Tuesday, October 13th
Healthcare Reform vs Innovation and Growth?
-
Novartis' Vanda Deal Is Great News- for Titan Pharma
-
Friday, October 9th
Keryx Biopharma Investors Should Wait for More News on Trials
-
Wednesday, October 7th
Time to Gain a Foothold in Transdel Pharma